MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517046462 A) filed by Immungenetics Ag, Hamburg, Germany, on May 14, for 'identifying a subject suffering from alzheimers dementia or being at risk of developing alzheimers dementia.'
Inventor(s) include Krohn Markus.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "In a first aspect the invention relates to a method for identifying a subject suffering from Alzheimers dementia (AD) or being at risk of developing Alzheimers dementia the method comprising: (a) determining in a first body fluid sample of the subject the amount of at least a compound having a mass in gram/mol of 110.0367; (b) determining in a second body fluid sample of the subject the amount of the same compound as in (a); (c) determining the change of the amount of the compound determined according to (a) compared to the respective amount of the compound determined according to (b); (d) analyzing the change as determined in (c) using a computer implemented prediction algorithm that is capable of predicting AD in a subject based on the compound whereby a subject suffering from AD or being at risk of developing Alzheimers dementia is identified if AD is predicted; wherein said first body fluid sample had been obtained prior to administration of thiethylperazine or a pharmaceutically acceptable salt thereof and said second body fluid sample had been obtained after the subject had been administered thiethylperazine or a pharmaceutically acceptable salt thereof."
The patent application was internationally filed on Oct. 17, 2023, under International application No.PCT/EP2023/078829.
Disclaimer: Curated by HT Syndication.
